{"title":"从印度2型糖尿病患者开始使用极低剂量(0.2mg)利拉鲁肽似乎耐受性更好:来自现实生活实践的经验","authors":"Majumder Anirban, Bhattacharjee Kingshuk","doi":"10.15406/JDMDC.2017.04.00127","DOIUrl":null,"url":null,"abstract":"Submit Manuscript | http://medcraveonline.com Keymessages: Clinicians may start with very low dose (0.2mg per day) liraglutide with subsequent weekly up-titration to minimize the gastrointestinal intolerance of liraglutide therapy, in obese and/or overweight Indian type 2 diabetes patients. Abbreviations: ADA: American Diabetes Association; BMI: Body Mass Index; DBP: Diastolic Blood Pressure; EASD: European Association for the Study of Diabetes; FPG: Fasting Plasma Glucose; GLP-1: Glucagon-Like Peptide-1; GI: Gastrointestinal; Volume 4 Issue 6 2017","PeriodicalId":92240,"journal":{"name":"Journal of diabetes, metabolic disorders & control","volume":"29 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2017-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":"{\"title\":\"Beginning with very low dose (0.2mg) liraglutide in indian type 2 diabetic patients appears better tolerated: experience from real life practice\",\"authors\":\"Majumder Anirban, Bhattacharjee Kingshuk\",\"doi\":\"10.15406/JDMDC.2017.04.00127\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Submit Manuscript | http://medcraveonline.com Keymessages: Clinicians may start with very low dose (0.2mg per day) liraglutide with subsequent weekly up-titration to minimize the gastrointestinal intolerance of liraglutide therapy, in obese and/or overweight Indian type 2 diabetes patients. Abbreviations: ADA: American Diabetes Association; BMI: Body Mass Index; DBP: Diastolic Blood Pressure; EASD: European Association for the Study of Diabetes; FPG: Fasting Plasma Glucose; GLP-1: Glucagon-Like Peptide-1; GI: Gastrointestinal; Volume 4 Issue 6 2017\",\"PeriodicalId\":92240,\"journal\":{\"name\":\"Journal of diabetes, metabolic disorders & control\",\"volume\":\"29 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-12-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of diabetes, metabolic disorders & control\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.15406/JDMDC.2017.04.00127\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of diabetes, metabolic disorders & control","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15406/JDMDC.2017.04.00127","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Beginning with very low dose (0.2mg) liraglutide in indian type 2 diabetic patients appears better tolerated: experience from real life practice
Submit Manuscript | http://medcraveonline.com Keymessages: Clinicians may start with very low dose (0.2mg per day) liraglutide with subsequent weekly up-titration to minimize the gastrointestinal intolerance of liraglutide therapy, in obese and/or overweight Indian type 2 diabetes patients. Abbreviations: ADA: American Diabetes Association; BMI: Body Mass Index; DBP: Diastolic Blood Pressure; EASD: European Association for the Study of Diabetes; FPG: Fasting Plasma Glucose; GLP-1: Glucagon-Like Peptide-1; GI: Gastrointestinal; Volume 4 Issue 6 2017
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
